688046 药康生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)5.0695.1577.74711.91817.316
总资产报酬率 ROA (%)4.0684.2656.5799.95512.895
投入资产回报率 ROIC (%)4.3104.5977.12811.02215.361

边际利润分析
销售毛利率 (%)64.01661.99267.61171.38374.330
营业利润率 (%)20.89917.37926.30833.67636.381
息税前利润/营业总收入 (%)20.31415.67123.63530.69335.815
净利润/营业总收入 (%)19.09415.98925.54131.87831.725

收益指标分析
经营活动净收益/利润总额(%)107.21489.46184.35471.65772.406
价值变动净收益/利润总额(%)5.3208.6788.8325.4377.979
营业外收支净额/利润总额(%)-0.108-0.128-1.488-0.1570.035

偿债能力分析
流动比率 (X)3.3024.6064.5246.8533.687
速动比率 (X)3.1744.4604.3956.6223.530
资产负债率 (%)22.22617.02217.57212.24725.491
带息债务/全部投入资本 (%)14.8368.7916.4692.6255.665
股东权益/带息债务 (%)552.3321,006.0781,389.3163,596.7631,552.634
股东权益/负债合计 (%)349.923487.471469.088716.557292.300
利息保障倍数 (X)-36.122-9.292-10.332-10.472-61.858

营运能力分析
应收账款周转天数 (天)182.361162.536131.518105.86095.648
存货周转天数 (天)80.61069.84086.25196.87484.413